| Name | Value |
|---|---|
| Revenues | 299.4M |
| Cost of Revenue | 136.6M |
| Gross Profit | 162.8M |
| Operating Expense | 243.8M |
| Operating I/L | -81.0M |
| Other Income/Expense | 3.1M |
| Interest Income | 3.7M |
| Pretax | -77.9M |
| Income Tax Expense | -17.7M |
| Net Income/Loss | -60.2M |
Penumbra, Inc. is a global medical device company specializing in the design, development, manufacturing, and marketing of a wide range of neurovascular and vascular medical devices. The company's product portfolio includes aspiration-based thrombectomy systems, neurovascular embolization coiling systems, neurovascular access systems, neurosurgical aspiration tools, detachable embolic coil systems, microcatheters, occlusion devices, and immersive computer-based technologies. Penumbra generates revenue through the sale of its medical devices, which are used in various neurovascular and vascular therapies, and are distributed through direct sales organizations and distributors.